{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:30:37Z","timestamp":1775093437015,"version":"3.50.1"},"reference-count":8,"publisher":"The Journal of Rheumatology","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.3899\/jrheum.190238","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T12:24:09Z","timestamp":1560601449000},"page":"1422.1-1424","source":"Crossref","is-referenced-by-count":2,"title":["Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis"],"prefix":"10.3899","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-7868","authenticated-orcid":false,"given":"SEZA","family":"OZEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SELCAN","family":"DEMIR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-2363","authenticated-orcid":false,"given":"EZGI DENIZ","family":"BATU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2019,6,15]]},"reference":[{"key":"2026040106401352000_46.10.1422.1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180331"},{"key":"2026040106401352000_46.10.1422.2","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2026040106401352000_46.10.1422.3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/rheumatology\/key262","article-title":"Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra","volume":"58","author":"Kearsley-Fleet","year":"2019","journal-title":"Rheumatology"},{"key":"2026040106401352000_46.10.1422.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.30128"},{"key":"2026040106401352000_46.10.1422.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141567"},{"key":"2026040106401352000_46.10.1422.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.134254"},{"key":"2026040106401352000_46.10.1422.7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.38296","article-title":"Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study","volume":"66","author":"Vastert","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026040106401352000_46.10.1422.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.23437"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.190238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:40:45Z","timestamp":1775050845000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.190238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":8,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.3899\/jrheum.190238"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.190238","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]}}}